Unsupervised walking therapy and atherosclerotic risk-factor management for patients with peripheral arterial disease: A pilot trial

2007 ◽  
Vol 33 (3) ◽  
pp. 318-324 ◽  
Author(s):  
Tracie C. Collins ◽  
Shawna L. Johnson ◽  
Julianne Souchek
Keyword(s):  
Risk Factor ◽  
Peripheral Arterial Disease ◽  
Pilot Trial ◽  
Arterial Disease ◽  
Risk Factor Management ◽  
Atherosclerotic Risk Factor ◽  
Peripheral Arterial

scholarly journals Atherosclerotic risk factor reduction in peripheral arterial disease

2002 ◽  
Vol 17 (12) ◽  
pp. 895-904 ◽  
Author(s):  
Mary McGrae McDermott ◽  
Elizabeth A. Hahn ◽  
Philip Greenland ◽  
David Cella ◽  
Judith K. Ockene ◽  
...  
Keyword(s):  
Risk Factor ◽  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Atherosclerotic Risk Factor ◽  
Risk Factor Reduction ◽  
Peripheral Arterial

scholarly journals Atherosclerotic risk factor control in patients with peripheral arterial disease

2005 ◽  
Vol 41 (5) ◽  
pp. 816-822 ◽  
Author(s):  
Thomas F. Rehring ◽  
Brian G. Sandhoff ◽  
Ryan S. Stolcpart ◽  
John A. Merenich ◽  
H. Whitton Hollis
Keyword(s):  
Risk Factor ◽  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Risk Factor Control ◽  
Atherosclerotic Risk Factor ◽  
Peripheral Arterial

Lipoprotein(a) as a unique primary risk factor for early atherosclerotic peripheral arterial disease

2021 ◽  
Vol 14 (6) ◽  
pp. e243231
Author(s):  
John Mayo ◽  
Thomas Hoffman ◽  
Ryan Smith ◽  
Dwight Kellicut
Keyword(s):  
Risk Factor ◽  
Cardiovascular Diseases ◽  
Peripheral Arterial Disease ◽  
Arterial Disease ◽  
Common Condition ◽  
Elevated Plasma ◽  
Early Screening ◽  
Lipoprotein A ◽  
Peripheral Arterial ◽  
Primary Risk Factor

Elevated plasma lipoprotein(a) is a relatively common condition that contributes to many cardiovascular diseases. However, the awareness and testing for this condition remain low. Herein, we present a case of an otherwise healthy and active man who developed symptoms of peripheral arterial disease starting at age 49, and was found to have hyper-lipoprotein(a) as his only notable risk factor. Diagnosis was not made until years later, after an extensive workup. Upon further screening, he was also found to have subclinical coronary and carotid artery atherosclerotic disease. The patient was treated with aspirin, statin, niacin and angioplasty to bilateral superficial femoral arteries with good symptom resolution. Early screening of his son also revealed a similarly elevated lipoprotein(a) level. It is important to raise awareness of this condition and its relationship to early-onset peripheral arterial disease so patients and their families can be appropriately identified, counselled and treated.

Sign in / Sign up

Export Citation Format

Share Document